Glenview Trust Co Increases Position in Lam Research Corporation $LRCX

Glenview Trust Co boosted its holdings in Lam Research Corporation (NASDAQ:LRCX) by 2.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 100,253 shares of the semiconductor company’s stock after buying an additional 1,993 shares during the quarter. Glenview Trust Co’s holdings in Lam Research were worth $43,443,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of LRCX. Brighton Jones LLC boosted its position in shares of Lam Research by 1,032.4% during the 4th quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock worth $1,025,000 after acquiring an additional 12,936 shares in the last quarter. Caxton Associates LLP purchased a new position in shares of Lam Research in the 1st quarter valued at about $239,000. Gabelli Funds LLC acquired a new stake in shares of Lam Research during the 2nd quarter worth about $253,000. NewEdge Advisors LLC raised its position in shares of Lam Research by 2.7% during the 2nd quarter. NewEdge Advisors LLC now owns 100,528 shares of the semiconductor company’s stock worth $9,785,000 after acquiring an additional 2,661 shares in the last quarter. Finally, Osterweis Capital Management Inc. lifted its stake in Lam Research by 5,206.7% during the second quarter. Osterweis Capital Management Inc. now owns 796 shares of the semiconductor company’s stock worth $77,000 after purchasing an additional 781 shares during the last quarter. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Lam Research Stock Performance

Shares of Lam Research stock opened at $318.58 on Friday. The firm’s fifty day simple moving average is $332.17 and its 200-day simple moving average is $289.05. The stock has a market capitalization of $398.65 billion, a price-to-earnings ratio of 55.31, a PEG ratio of 1.24 and a beta of 1.84. Lam Research Corporation has a 12 month low of $94.11 and a 12 month high of $438.50. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.63 and a quick ratio of 1.91.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, topping analysts’ consensus estimates of $1.69 by $0.13. The firm had revenue of $6.72 billion during the quarter, compared to analysts’ expectations of $6.66 billion. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. Lam Research’s quarterly revenue was up 30.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.33 EPS. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, equities analysts forecast that Lam Research Corporation will post 9.32 earnings per share for the current year.

Lam Research Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 14th. Stockholders of record on Wednesday, September 23rd will be paid a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 0.4%. This is a positive change from Lam Research’s previous quarterly dividend of $0.26. The ex-dividend date is Wednesday, September 23rd. Lam Research’s payout ratio is currently 18.06%.

Lam Research News Summary

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam Research raised its quarterly dividend by 27%, from $0.26 to $0.33 per share. The payment is scheduled for October 14, 2026, to shareholders of record on September 23. The increase signals confidence in cash generation and enhances shareholder returns, although future payments remain subject to board approval. Lam Research Corporation Announces a 27% Increase in Quarterly Dividend
• Positive Sentiment: The company broke ground on a 120,000-square-foot Oregon research laboratory as part of a more than $3 billion, five-year expansion of its global lab network. The investment is intended to accelerate equipment and process innovations for advanced AI chips and deepen collaboration with major customers, supporting Lam’s long-term AI-driven growth outlook. Lam Research Breaks Ground on New Oregon Lab
• Positive Sentiment: Recent operating momentum remains supportive: Lam’s latest reported quarter exceeded earnings and revenue expectations, with revenue up 30% year over year. Its exposure to AI-related chip manufacturing, recurring services revenue and strong balance sheet were also cited as reasons it may be preferable to some other chip stocks. Lam Research vs. Microchip
• Neutral Sentiment: Directors Michael R. Cannon and Sohail U. Ahmed are retiring from Lam Research’s board. The planned governance transition does not appear to change the company’s near-term business outlook, but investors may monitor board succession and strategic continuity. Lam Research Announces Director Retirements
• Neutral Sentiment: Chief Financial Officer Doug Bettinger is scheduled to participate in upcoming investor conferences, potentially providing additional commentary on semiconductor demand, AI spending and company guidance. Lam Research Announces Participation at Upcoming Conferences
• Negative Sentiment: Mizuho lowered its price target for Lam Research to $365, a potentially cautionary signal regarding valuation or near-term semiconductor-equipment conditions. The revised target remains above the price level described in the market background, limiting the severity of the negative read-through. Mizuho Lowers Lam Research Price Target

Insider Buying and Selling

In related news, Director Abhijit Y. Talwalkar sold 18,282 shares of the business’s stock in a transaction dated Monday, July 13th. The stock was sold at an average price of $335.00, for a total value of $6,124,470.00. Following the transaction, the director owned 87,142 shares in the company, valued at $29,192,570. The trade was a 17.34% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the company’s stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total value of $19,118,600.00. Following the sale, the director directly owned 199,205 shares of the company’s stock, valued at approximately $69,881,114. This represents a 21.48% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 80,441 shares of company stock valued at $27,614,296 over the last quarter. 0.31% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

LRCX has been the subject of several research analyst reports. Raymond James Financial set a $425.00 target price on shares of Lam Research in a report on Wednesday, June 10th. Needham & Company LLC reiterated a “buy” rating and set a $390.00 price target on shares of Lam Research in a research note on Thursday, July 30th. HSBC reissued a “hold” rating and issued a $333.00 price target on shares of Lam Research in a research report on Monday, July 27th. Jefferies Financial Group set a $335.00 price objective on Lam Research and gave the stock a “buy” rating in a report on Thursday, July 30th. Finally, Morgan Stanley cut their target price on Lam Research from $404.00 to $367.00 and set an “overweight” rating on the stock in a research report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $357.31.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.